Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein.

Anderson, Trevor S; McCormick, Amanda L; Smith, Savanna L; Lowe, Devin B

Anderson, Trevor S; McCormick, Amanda L; Smith, Savanna L; Lowe, Devin B.

Afiliación

Anderson TS; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Office 1306, Abilene, TX, 79601, USA.
McCormick AL; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Office 1306, Abilene, TX, 79601, USA.
Smith SL; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Office 1306, Abilene, TX, 79601, USA.
Lowe DB; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Office 1306, Abilene, TX, 79601, USA. devin.lowe@ttuhsc.edu.

BMC Biol ; 22(1): 66, 2024 Mar 14.

Article en En | MEDLINE | ID: mdl-38486229

Asunto(s)

Antineoplásicos; Inmunoconjugados; Humanos; Inmunoconjugados/farmacología; Inmunoconjugados/química; Granzimas; alfa-Fetoproteínas; Antineoplásicos/química; Antineoplásicos/farmacología; Antineoplásicos/uso terapéutico; Anticuerpos Monoclonales; Línea Celular Tumoral

Palabras clave

Antibody drug conjugate; Antibody fusion protein; Granzyme B

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoconjugados / Antineoplásicos Límite: Humans Idioma: En Revista: BMC Biol Asunto de la revista: BIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google